Previously, Ms. Halstrom has served in senior communications roles at Pfizer, GlaxoSmithKline and Bristol Myers Squibb.
The news comes as GE prepares for the January spinoff by naming its board of directors and setting a Dec. 8 investor day.
“Together, we have an unprecedented opportunity to leverage a trusted brand, introduce a new company and deliver solutions for patients with passion and focus,” Ms. Halstrom wrote in an Oct. 26 LinkedIn post.
